Abstract
First WHO meeting of stakeholders on elimination of gambiense Human African Trypanosomiasis.
Highlights
Human African Trypanosomiasis (HAT), known as Sleeping Sickness, has been one of the most important human diseases in Africa because of widespread epidemics in the past, its very high level of mortality, and its negative influence on the development of rural populations
As a result of these outstanding efforts by national sleeping sickness programmes and the support of international organizations led by the World Health Organization (WHO), and involving key pharmaceutical companies and major international donors, remarkable results have been achieved during the past 15 years, with the number of new reported cases falling to 6,228 in 2013 [4]
The 2020 target was included in the WHO roadmap for elimination and control of neglected tropical diseases [5], and it is defined as the reduction of gambiense HAT incidence to less than 1 new case per 10,000 population at risk, in at least 90% of foci with fewer than 2000 cases reported globally [4,5,6]
Summary
Human African Trypanosomiasis (HAT), known as Sleeping Sickness, has been one of the most important human diseases in Africa because of widespread epidemics in the past, its very high level of mortality, and its negative influence on the development of rural populations. The alarming rise in the number of cases stimulated international efforts to reverse the epidemiological trend and reduce the incidence of the disease, using enhanced surveillance and improved access to diagnosis and treatment in endemic countries [1,2].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
